Nasus Pharma NSRX
NYSE NSRX
$3.78 +0.21 (+5.82%)
As of: Sep 30, 2026 · 2:14 PM EDT

Nasus Pharma (NSRX) Retained Earnings (2024 - 2026)

Updated

Nasus Pharma (NSRX) posted Retained Earnings of -$24.46 million for Q2 2026, compared with -$13.92 million a year earlier.

Analysis

Nasus Pharma (NSRX) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma's Retained Earnings came in at -$18.52 million.

  • In prior years, Nasus Pharma's Retained Earnings was -$12.66 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 171.67 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -17.33 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 40.86 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 12.59 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -22.28 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 2.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 112.09 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 15.69 Bn
10 Nasus Pharma 32.55 Mn 32.55 Mn - -24.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.46 Mn
Dec 31, 2025 -18.52 Mn
Jun 30, 2025 -13.92 Mn
Dec 31, 2024 -12.66 Mn
API Access

Nasus Pharma Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=NSRX&period=max&api_key=YOUR_API_KEY